Eli Lilly secured EU regulatory backing for its oral GLP-1 pill orforglipron on Friday as it looks to catch up with competitor Novo’s Wegovy pill.
…
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.